Putin's Daughter Leads Russia's $26 Billion Longevity Initiative
Maria Vorontsova, Vladimir Putin's daughter, leads Russia's $26 billion longevity initiative. While scientists explore anti-aging therapies at Skolkovo, Russia faces severe demographic challenges due to low male life expectancy and war casualties.
Maria Vorontsova, the 41-year-old endocrinologist and eldest daughter of Russian President Vladimir Putin, leads the Medical Research and Education Institute at Moscow University, overseeing state-backed longevity programs. Together with Putin's childhood friends Mikhail and Yuri Kovalchuk, she manages state-funded projects worth $26 billion. A new longevity research laboratory recently opened at the Skolkovo innovation center near Moscow, where Vorontsova told researchers that medicine must address the universal human fear of death, though breakthroughs will take decades.
The National Longevity Strategy and Challenges
The national initiative comprises two main phases. The first aims to achieve a natural life expectancy of 85 to 90 years through healthy habits. The second phase involves active medical intervention, including gene therapy, organ transplants, and xenotransplantation. Vorontsova noted that such measures might be seen as "cheating God or nature," conflicting with traditional Christian values promoted by Putin and Patriarch Kirill. Scientists are also working on a cellular aging vaccine under the "Long and Active Life" program.
However, Russia faces severe demographic hurdles. Life expectancy stands at 67 years for men and 78 for women. Putin has set targets to raise life expectancy to 78 years by 2030 and 81 years by 2036. Deputy Prime Minister Tatyana Golikova announced plans to launch an anti-aging drug production between 2028 and 2030 as part of the "New Health Preservation Technologies" national project.
The Impact of the War in Ukraine
The demographic crisis is exacerbated by excess male mortality caused by the COVID-19 pandemic and the war in Ukraine. Economist Vladislav Inozemtsev termed this a "death economy," where military recruitment bonuses and compensation for fallen soldiers provide families with unprecedented sums. With an estimated 500,000 casualties, the conflict remains a heavy burden. Meanwhile, President Putin, who turns 74 and aims to stay in power until 2036, remains deeply fascinated by biotechnology and the prospect of extended human lifespans.
